Sohini Das
 "Sohini Das")
Sohini Das
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Page 24 - Sohini Das
US, UK in focus as pharma companies eye $31 billion exports in FY25
Industry also working to pump up business in Africa and Russia, regions battling geopolitical crises
 "US, UK in focus as pharma companies eye $31 billion exports in FY25")
Deepening presence in Tier-III may be Dr Lal PathLabs' growth pill
Manchanda highlights that the 'white-spaces' for them are going deeper in strong markets
 "Deepening presence in Tier-III may be Dr Lal PathLabs' growth pill")
Indian pharmaceutical companies likely to cash in on US drug shortages
US drug shortages hit a decade-high of 323 across 22 therapies in the March quarter of 2024
 "Indian pharmaceutical companies likely to cash in on US drug shortages")
Second-gen promoters more open to selling out: Rothschild MD Subhakanta Bal
In pharma areas like high potency APIs, sterile manufacturing capabilities, antibody drug conjugates, peptides etc are areas that are growing fast and there is an inherent entry barrier
 "Second-gen promoters more open to selling out: Rothschild MD Subhakanta Bal")
India to make JLR's Range Rover for first time, delivery starts May 24
Prices of 'flagship car' and its sport variant will reduce by 18-22%, say senior executives of Tata Motors-owned company
 "India to make JLR's Range Rover for first time, delivery starts May 24")
On the path to carbon neutrality, six EVs to come in 4 years: JLR India MD
We have the full EV starting with the Range Rover around the end of next year, Amba said
 "On the path to carbon neutrality, six EVs to come in 4 years: JLR India MD")
US-based firm Taro's shareholders approve merger with Sun Pharmaceutical
The merger agreement between Sun Pharma and Taro was approved by an affirmative vote of Taro shareholders at an extraordinary general meeting and an ordinary class meeting on May 22
 "US-based firm Taro's shareholders approve merger with Sun Pharmaceutical")
Moved imp products out of Mohali, Dadra plants: Sun Pharma's Abhay Gandhi
Speaking to Sohini Das over a video interview from the US, Abhay Gandhi, CEO, North America of Sun Pharma outlines his plan for the company's specialty business
 "Moved imp products out of Mohali, Dadra plants: Sun Pharma's Abhay Gandhi")
Sun Pharma Q4 result: Profit up 33% over strong US, specialty sales
Firm guides for high single-digit top line, higher R&D spend in FY25; board approves appointment of Dilip Shanghvi as chairman
 "Sun Pharma Q4 result: Profit up 33% over strong US, specialty sales")
Serum Institute ships its first set of malaria vaccine doses to Africa
The vaccine has been developed in collaboration with the University of Oxford and Novavax's Matrix-M adjuvant
 "Serum Institute ships its first set of malaria vaccine doses to Africa")
Covid vaccine makers gear up to launch new-generation jabs in India
India currently does not have any XBB 1.5 variant-based vaccines in the market
 "Covid vaccine makers gear up to launch new-generation jabs in India")
Tata Motors to invest Rs 43,000 crore in products and technologies in FY25
Analysts expect JLR margins to remain stable
 "Tata Motors to invest Rs 43,000 crore in products and technologies in FY25")
Fuelling change? M&M may consider hybrid tech shift if demand arises
Automaker puts EVs and ICE in the driver's seat amid hybrid emission concerns
 "Fuelling change? M&M may consider hybrid tech shift if demand arises")
Auto major M&M shifts to high gear with Rs 37,000 crore investments
CEO says EVs will constitute 20-30% of its overall sales by 2027
 "Auto major M&M shifts to high gear with Rs 37,000 crore investments")
M&M Q4 results: PAT rises 4% to Rs 2,754 crore on strong auto biz
Farm business PAT grew 2 per cent in FY24 when industry volumes declined
 "M&M Q4 results: PAT rises 4% to Rs 2,754 crore on strong auto biz")
Lapses in BHU research on Covid-19 vaccine Covaxin, says Bharat Biotech
Nearly 363 mn doses of Covaxin have been administered in India so far, second only to AstraZeneca-Serum Institute of India's Covishield
 "Lapses in BHU research on Covid-19 vaccine Covaxin, says Bharat Biotech")
Cipla promoters sell 2.53% stake worth Rs 2,637 cr to fund philanthropy
ICICI Prudential MF, Aditya Birla Sun Life MF among top buyers
 "Cipla promoters sell 2.53% stake worth Rs 2,637 cr to fund philanthropy")
Recharge zones to cool clothing: Indian companies' summer strategies
Several firms are stepping up to help their workforce cope with soaring temperatures
 "Recharge zones to cool clothing: Indian companies' summer strategies")
Piramal Pharma open to partnerships in OTC; eyes further debt reduction
Piramal said that they are focusing on organic growth across all their verticals - OTC business in India, complex hospital generics, and the Contract Development and Manufacturing (CDMO) business
 "Piramal Pharma open to partnerships in OTC; eyes further debt reduction")
Does the country need to continue with Covid-19 vaccination drive?
Experts feel paid vaccine shots should continue to be available for elderly and comorbid
 "Does the country need to continue with Covid-19 vaccination drive?")
